Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer

被引：194
作者：
Winter, Jordan M. [1 ]
Yeo, Charles J. [1 ]
Brody, Jonathan R. [1 ]
机构：
[1] Thomas Jefferson Univ, Dept Surg, Philadelphia, PA 19107 USA
来源：
JOURNAL OF SURGICAL ONCOLOGY | 2013年 / 107卷 / 01期
关键词：
pancreatic cancer; pancreatic ductal adenocarcinoma; biomarkers; predictive markers; prognostic markers; SERUM CA-19-9 LEVELS; GENE-EXPRESSION; ADJUVANT CHEMOTHERAPY; PHOSPHOGLYCERATE KINASE-1; DUCTAL ADENOCARCINOMA; CA19-9; LEVELS; SURVIVAL; GEMCITABINE; RECURRENCE; IDENTIFICATION;
D O I：
10.1002/jso.23192
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Serum CA 19-9 is the only FDA approved biomarker recommended for use in the routine management of pancreatic ductal adenocarcinoma (PDA). Over 2,000 biomarker studies related to pancreatic cancer appear in the literature, highlighting the need to discover and develop improved tests. Diagnostic biomarkers have implications for early detection of PDA, prognostic markers predict patient survival and recurrence patterns, and predictive markers can help personalize treatment regimens. J. Surg. Oncol. 2013;107:1522. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码：15 / 22
页数：8
相关论文
共 50 条
  • [31] Circulating microRNAs as diagnostic biomarkers for pancreatic cancer
    Le Large, Tessa Y. S.
    Meijer, Laura L.
    Prado, Mireia Mato
    Kazemier, Geert
    Frampton, Adam E.
    Giovannetti, Elisa
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2015, 15 (12) : 1525 - 1529
  • [32] Prognostic and predictive biomarkers post curative intent therapy
    Feldman, Rebecca
    Kim, Edward S.
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (18)
  • [33] Diagnostic and prognostic biomarkers for pancreatic neuroendocrine neoplasms
    Sonnen, Andreas F. -P.
    Verschuur, Anna Vera D.
    Brosens, Lodewijk A. A.
    PATHOLOGIE, 2024, 45 (SUPPL1): : 74 - 82
  • [34] Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer
    Zandberga, Elina
    Kozirovskis, Viktors
    Abols, Arturs
    Andrejeva, Diana
    Purkalne, Gunta
    Line, Aija
    GENES CHROMOSOMES & CANCER, 2013, 52 (04) : 356 - 369
  • [35] A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer
    Hank, Thomas
    Hinz, Ulf
    Reiner, Thomas
    Malleo, Giuseppe
    Koenig, Anna-Katharina
    Maggino, Laura
    Marchegiani, Giovanni
    Kaiser, Joerg
    Paiella, Salvatore
    Binco, Alessandra
    Salvia, Roberto
    Hackert, Thilo
    Bassi, Claudio
    Buechler, Markus W.
    Strobel, Oliver
    ANNALS OF SURGERY, 2022, 276 (06) : E914 - E922
  • [36] The clinical utility of CA125/MUC16 in pancreatic cancer: A consensus of diagnostic, prognostic and predictive updates by the Chinese Study Group for Pancreatic Cancer (CSPAC)
    Liu, Liang
    Xiang, Jinfeng
    Chen, Rufu
    Fu, Deliang
    Hong, Defei
    Hao, Jihui
    Li, Yixiong
    Li, Jiangtao
    Li, Shengping
    Mou, Yiping
    Mai, Gang
    Ni, Quanxing
    Peng, Li
    Qin, Renyi
    Qian, Hongang
    Shao, Chenghao
    Sun, Bei
    Sun, Yongwei
    Tao, Min
    Tian, Bole
    Wang, Hongxia
    Wang, Jian
    Wang, Liwei
    Wang, Wei
    Wang, Weilin
    Zhang, Jun
    Zhao, Gang
    Zhou, Jun
    Yu, Xianjun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (03) : 900 - 907
  • [37] An Integrated Bioinformatics Analysis towards the Identification of Diagnostic, Prognostic, and Predictive Key Biomarkers for Urinary Bladder Cancer
    Sarafidis, Michail
    Lambrou, George, I
    Zoumpourlis, Vassilis
    Koutsouris, Dimitrios
    CANCERS, 2022, 14 (14)
  • [38] The minimum apparent diffusion coefficient value on preoperative magnetic resonance imaging in resectable pancreatic cancer: a new prognostic factor for biologically borderline resectable pancreatic cancer
    Matsumoto, Michinori
    Tsunematsu, Masashi
    Hamura, Ryoga
    Haruki, Koichiro
    Furukawa, Kenei
    Shirai, Yoshihiro
    Uwagawa, Tadashi
    Onda, Shinji
    Taniai, Tomohiko
    Tanji, Yoshiaki
    Yanagaki, Mitsuru
    Ikegami, Toru
    SURGERY TODAY, 2025,
  • [39] Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer
    Merz, Valeria
    Mangiameli, Domenico
    Zecchetto, Camilla
    Quinzii, Alberto
    Pietrobono, Silvia
    Messina, Carlo
    Casalino, Simona
    Gaule, Marina
    Pesoni, Camilla
    Vitale, Pasquale
    Trentin, Chiara
    Frisinghelli, Michela
    Caffo, Orazio
    Melisi, Davide
    FRONTIERS IN SURGERY, 2022, 9
  • [40] MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators
    Daoud, Afra Z.
    Mulholland, Eoghan J.
    Cole, Grace
    McCarthy, Helen O.
    BMC CANCER, 2019, 19 (01)
12345